These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15710654)

  • 21. Application of stopped-flow kinetics methods to investigate the mechanism of action of a DNA repair protein.
    Biro FN; Zhai J; Doucette CW; Hingorani MM
    J Vis Exp; 2010 Mar; (37):. PubMed ID: 20357752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the DNA-binding activity of Saccharomyces cerevisiae MSH2-MSH6 complex by the high-mobility group protein NHP6A, in vitro.
    Labazi M; Jaafar L; Flores-Rozas H
    Nucleic Acids Res; 2009 Dec; 37(22):7581-9. PubMed ID: 19843605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases.
    Wang H; Lawrence CW; Li GM; Hays JB
    J Biol Chem; 1999 Jun; 274(24):16894-900. PubMed ID: 10358035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions.
    Larson ED; Duquette ML; Cummings WJ; Streiff RJ; Maizels N
    Curr Biol; 2005 Mar; 15(5):470-4. PubMed ID: 15753043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.
    Xiao Z; Ray M; Jiang C; Clark AB; Rogozin IB; Diaz M
    Mol Immunol; 2007 Apr; 44(10):2659-66. PubMed ID: 17240451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saccharomyces cerevisiae MSH2-MSH3 and MSH2-MSH6 complexes display distinct requirements for DNA binding domain I in mismatch recognition.
    Lee SD; Surtees JA; Alani E
    J Mol Biol; 2007 Feb; 366(1):53-66. PubMed ID: 17157869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
    Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
    Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification.
    Li Z; Scherer SJ; Ronai D; Iglesias-Ussel MD; Peled JU; Bardwell PD; Zhuang M; Lee K; Martin A; Edelmann W; Scharff MD
    J Exp Med; 2004 Jul; 200(1):47-59. PubMed ID: 15238604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of the MSH2.MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA.
    Lau PJ; Kolodner RD
    J Biol Chem; 2003 Jan; 278(1):14-7. PubMed ID: 12435741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
    Campbell MR; Thang TY; Jirik FR; Andrew SE
    Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of DNA polymerase eta reveals targeting of C mutations on the nontranscribed strand in immunoglobulin switch regions.
    Zeng X; Negrete GA; Kasmer C; Yang WW; Gearhart PJ
    J Exp Med; 2004 Apr; 199(7):917-24. PubMed ID: 15051760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.
    Zanotti KJ; Gearhart PJ
    DNA Repair (Amst); 2016 Feb; 38():110-116. PubMed ID: 26719140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
    Ehrenstein MR; Neuberger MS
    EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs.
    Steele EJ
    Mol Immunol; 2009 Jan; 46(3):305-20. PubMed ID: 19062097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T.
    Neuberger MS; Rada C
    J Exp Med; 2007 Jan; 204(1):7-10. PubMed ID: 17190841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different mutation signatures in DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody diversification.
    Martomo SA; Yang WW; Wersto RP; Ohkumo T; Kondo Y; Yokoi M; Masutani C; Hanaoka F; Gearhart PJ
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8656-61. PubMed ID: 15939880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.